文献速递慢性静脉疾病静脉血栓栓塞

经皮与杂交介入重建股-髂-腔静脉流出道治疗症状性深静脉梗阻

Editor's Choice - Reconstruction of the femoro-ilio-caval outflow by percutaneous and hybrid interventions in symptomatic deep venous obstruction.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-08-01

该前瞻性队列研究纳入369例患者共425条下肢,比较经皮支架治疗非血栓性髂静脉压迫综合征(IVCS)、血栓后综合征(PTS)经皮支架组(P-PTS)及需杂交手术的PTS组(H-PTS)的中期通畅率与临床结局。结果显示IVCS组60个月一期通畅率90%,P-PTS组64%,H-PTS组36个月仅37%;H-PTS组并发症率81%、再干预率59%最高,但成功者临床结局良好。

要点

  • 非血栓性髂静脉压迫经皮支架通畅率优良,60个月一期通畅率90%。
  • 血栓后综合征经皮支架组60个月一期通畅率64%,低于IVCS组。
  • 需杂交手术的晚期PTS组36个月一期通畅率仅37%,并发症与再干预率最高。

核心结论

  • 经皮支架治疗非血栓性髂静脉病变及血栓后髂股静脉梗阻安全有效,通畅率与既往研究相当。
  • 需杂交手术的晚期病变患者通畅率较低、并发症更多,但成功者中期临床结局良好,可考虑用于选择患者。

研究设计与样本

  • 前瞻性分析队列研究,纳入369例患者共425条下肢,分为IVCS组、P-PTS组和H-PTS组。

主要发现

  • 60个月一期、辅助一期和二期通畅率:IVCS组分别为90%、100%、100%,P-PTS组分别为64%、81%、89%。
  • H-PTS组36个月一期、辅助一期和二期通畅率分别为37%、62%、72%。
  • 静脉性跛行缓解率在IVCS、P-PTS和H-PTS组分别为90%、82%和83%。
  • 24个月随访时所有患者平均静脉临床严重程度评分下降,血栓后患者Villalta评分改善。
  • H-PTS组并发症率81%、再干预率59%,为三组最高,并发症数量与深静脉梗阻范围相关。

临床怎么用

  • 非血栓性髂静脉压迫和血栓后髂股静脉梗阻可优先考虑经皮支架治疗。
  • 需杂交手术的晚期病变应充分评估风险,选择合适患者并在成功手术时预期良好中期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: Deep venous obstruction is relatively prevalent in patients with chronic venous disease. Endovascular treatments and hybrid interventions can be used to relieve venous outflow obstructions. This paper assesses mid-term clinical outcomes and patency rates in a large cohort after percutaneous and hybrid interventions. METHODS: This was a prospectively analysed cohort study. Patients with symptomatic deep venous obstruction who presented at a tertiary referral hospital were divided into three groups: patients who underwent percutaneous stenting for non-thrombotic iliac vein compression syndrome (IVCS group); patients with post-thrombotic syndrome (PTS) treated by percutaneous stent placement (P-PTS group); and PTS patients with obstruction involving the veins below the saphenofemoral junction in which a hybrid procedure was performed, combining stenting with open surgical disobliteration (H-PTS group). Patency rates, complications, and clinical outcomes were analysed. RESULTS: A total of 425 lower extremities in 369 patients were treated. At 60 months, primary patency, assisted primary patency, and secondary patency rates were 90%, 100%, and 100% for IVCS, and 64%, 81%, and 89% for the P-PTS group, respectively. The H-PTS group, showed patency rates of 37%, 62%, and 72%, respectively, at 36 months. Venous claudication subsided in 90%, 82%, and 83%, respectively. At the 24 month follow-up, mean Venous Clinical Severity Score decreased for all patients and improvement in Villalta score was seen in post-thrombotic patients. The number of complications was related to the extent of deep venous obstruction in which patients in the H-PTS group showed the highest complication rates (81%) and re-interventions (59%). CONCLUSION: Percutaneous stent placement to treat non-thrombotic iliac vein lesions, and post-thrombotic ilio-femoral obstructions are safe, effective, and showed patency rates comparable with previous research. Patients with advanced disease needing a hybrid procedure showed a lower patency rate and more complications. However, when successful, the clinical outcome was favourable at mid-term follow-up and the procedure may be offered to selected patients.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. van Vuuren TMAJ, de Wolf MAF, Arnoldussen CWKP, et al. Editor's Choice - Reconstruction of the femoro-ilio-caval outflow by percutaneous and hybrid interventions in symptomatic deep venous obstruction. Eur J Vasc Endovasc Surg. 2017. PMID: 28778457. doi:10.1016/j.ejvs.2017.06.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。